⌕
Synergetics USA · SURG · Nasdaq
Tenet 16 · Weak
Compare
$0.14−2.25%At closeTenet 16 · Weak
$0.140.00 (−2.25%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD

Synergetics USA (SURG) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue is 58% below its peak, net margin −63.3%. Worth your attention in FY25: Share count (+358.4%) and Returns vs FCF (n/m). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼6.4%
57.0
FY21→FY25CAGR +2.8%/yr
Net income ($M)▲21.1%
−36.1
one-off year: see footnoteCAGR —
Free cash flow ($M)▲2.4%
−21.3
FY21→FY25CAGR —
Diluted EPS▲24.7%
−1.80
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Stock comp vs FCF
−4.4%

of free cash flow goes to stock comp (was −0.0% in FY21). Owner-earnings math treats it as a real cost.

Share count
+358.4%

4.4mn → 20.1mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$18.6K

−96.4% YoY in FY25 · 0.0% of revenue.

Returns vs FCF
n/m

$0.0M returned vs $−21.3M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)57.0Revenue−67.6COGS−10.6Gross profit0.0R&D−20.1SG&A−34.1Op income−1.9Tax & other−36.1Net income

-63¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
30231580%FY21FY25

Over this window: gross 12.1% → -18.6%. Net margin -63.3% is below the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
The annual and quarterly statements are struck on share counts that differ by a factor of 0.7892, so per-share figures cannot be compared across the two tables. Each table's per-share figures are on its own share basis.
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
56,962.956,962.960,881.2137,141.8121,544.251,060.6▼6.4%+2.8%
Cost of revenue
67,551.867,551.875,205.4101,499.3108,074.844,890.6▼10.2%+10.8%
Gross profit
−10,588.9−10,588.9−14,324.235,642.513,469.46,170.0▲26.1%—
Research & development
0.00.00.00.00.00.0——
Selling, general & admin
20,071.120,071.126,292.915,713.011,911.811,378.3▼23.7%+15.2%
Total operating expenses
23,548.023,548.027,458.216,777.112,835.612,162.5▼14.2%+18.0%
Operating incomefeeds ROC rank
−34,136.9−34,136.9−41,782.418,865.4633.8−5,992.6▲18.3%—
Other income, net
−1,932.8−1,932.8−1,285.4−485.8−1,187.0−7,538.6——
Pretax income
−36,069.7−36,069.7−43,067.818,379.6−553.2−13,531.1▲16.2%—
Income tax
0.00.02,870.0−2,265.00.00.0——
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−36,069.7−36,069.7−45,729.220,617.9−680.8−13,531.1▲21.1%—
Per share
Diluted EPSbuyback-sensitive
−1.80−1.80−2.391.38−0.05−3.09▲24.7%—
Diluted shares (mn)
20.0920.0919.1214.9212.404.38▲5.1%+46.3%
Margins
Gross margin1st pct in Healthcare
−18.6%−18.6%−23.5%26.0%11.1%12.1%▲4.9pp−30.7pp
Operating margin
−59.9%−59.9%−68.6%13.8%0.5%−11.7%▲8.7pp−48.2pp
Net margin28th pct in Healthcare
−63.3%−63.3%−75.1%15.0%−0.6%−26.5%▲11.8pp−36.8pp
† TTM = fiscal 2025, through 2025-12-31. The newest fiscal year already covers the newest quarter we hold, so the trailing twelve months are that year and this column repeats its figures.FY23 effective tax rate was −12% vs a 0% norm for this window, likely a one-time item; see the filing.
FY10 – FY20 · 11 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 11 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-04-15 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Synergetics USA's revenue last fiscal year?

Synergetics USA reported revenue of $57.0M in fiscal 2025, down 6.4% from fiscal 2024.

What was Synergetics USA's net income?

Synergetics USA reported net income of −$36.1M in fiscal 2025, a net margin of −63.3%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.